Clinical trial

AI for Lung Cancer Risk Definition in Computed Tomography Screening Programs

NCT06320184

StatusACTIVE_NOT_RECRUITING

Study typeOBSERVATIONAL

Start date2023-04-30

PhaseN/A

Study timeline

Study start (actual)2023-04-30Date precision: day

Registry last updated2026-03-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancerunresolved

Blood Biomarkersunresolved

Interventions

Artificial Intelligence risk modelDIAGNOSTIC_TEST

Sponsors & collaborators

Fondazione IRCCS Istituto Nazionale dei Tumori, Milanolead sponsor

University of Milano Bicoccacollaborator

Mapped research locations

MilanItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06320184 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.